Label: DERMAN ANTIFUNGAL POWDER TOLNAFTATE- tolnaftate aerosol, powder
- NDC Code(s): 81929-001-01
- Packager: Taisho Pharmaceutical California Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated November 10, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Active ingredient
- Uses
-
Warnings
For external use only
Contents under pressure. Do not puncture or incinetare or store at a temperature above 120°F. Use only as directed. Intentional misuse by deliberately concentrating and inhaling aerosol products can be harmful or fatal. Do not use near flame or spark or white smoking. Flammable:
-
Directions
- clean the affected area and dry thoroughly
- shake can well before use: hold can about 6 inches from the area to be treated
- apply a thin layer over the affected area twice daily (morning and night), or as directed by a doctor
- supervise children in the use of this product
- use daily for 4 weeks for athlete's foot and ringworm; use daily for 2 weeks for jock itch
- to prevent most athlete's foot apply once or twice daily (morning and/or night)
- if condition persists longer, consult a doctor
- this product is not effective on the scalp or nails
- for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily
- Other information
- Inactive ingredients
- Package Labeling:
-
INGREDIENTS AND APPEARANCE
DERMAN ANTIFUNGAL POWDER TOLNAFTATE
tolnaftate aerosol, powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:81929-001 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE 10 mg in 1 g Inactive Ingredients Ingredient Name Strength BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) STARCH, CORN (UNII: O8232NY3SJ) ISOBUTANE (UNII: BXR49TP611) KAOLIN (UNII: 24H4NWX5CO) PPG-12-BUTETH-16 (UNII: 58CG7042J1) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:81929-001-01 1 in 1 BOX 05/01/2022 1 130 g in 1 CAN; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M005 05/01/2022 Labeler - Taisho Pharmaceutical California Inc. (603827635)
